In addition, evaluations of serum ALT levels, hepatic TG, and H&E staining of liver tissue revealed that liver damage and steatosis were obviously alleviated in IL-10−/− mice compared with WT controls (Figures 10D–F). The gene discussed is IL10; the disease is steatosis.